Skip to content
Research/Regenerative Aesthetics/Extracorporeal Shockwave Therapy

Extracorporeal Shockwave Therapy

Extracorporeal shockwave therapy (ESWT) is a non-invasive treatment that uses acoustic waves to promote healing and regeneration in tissues. It is primarily used for musculoskeletal conditions, enhancing blood flow and stimulating cellular repair processes. This therapy is gaining attention for its potential in improving recovery and function, which is relevant for longevity and health optimization.

Intelligence Profile

Research Papers

Extracorporeal Shockwave Therapy (ESWT) is being explored across various medical conditions, highlighting its versatility in treatment. Key research papers and clinical trials have investigated its efficacy in different contexts:

  1. Endometriosis: A study in the Biomedical Journal examined low-energy ESWT in an estrogen-induced rat model, showing reduced inflammation and fibrosis. This suggests potential for alleviating symptoms in endometriosis, even under menopause-like conditions.

  2. Tendon Injuries: A case report in "Life (Basel)" highlighted positive outcomes for a professional football player with peroneus longus tendon tear treated with focused ESWT. This conservative approach showed excellent clinical and radiological results, suggesting promise in sports medicine.

  3. Erectile Dysfunction: A meta-analysis correction in International Urology and Nephrology reviewed randomized controlled trials on low-intensity ESWT for erectile dysfunction post-prostatectomy, emphasizing its potential benefit. Further trials are ongoing (e.g., NCT06433596), focusing on combined therapies like PRP and shock waves.

  4. Rotator Cuff Tendinitis: A randomized controlled trial (Arthroscopy Journal) compared ultrasound-guided needling to high-energy shockwave therapy for rotator cuff calcific tendinitis, finding comparable midterm outcomes, indicating ESWT as a viable alternative.

  5. Temporomandibular Disorders: A meta-analysis in Frontiers in Rehabilitation Sciences supported ESWT's efficacy in reducing pain and improving function for temporomandibular disorders, marking it as an effective non-invasive option.

  6. Spasticity and Pain Management: Clinical trials like NCT07043335 and NCT07695038 are examining ESWT's efficacy for lateral epicondylitis and post-stroke spasticity, respectively. While results are pending, these trials highlight the therapy's expanding applications.

In summary, ESWT shows promise in inflammation reduction, tissue repair, and pain management across various conditions. However, ongoing and future trials are necessary to better define its clinical effectiveness and establish standardized treatment protocols.

Disclaimer:
This summary is for informational purposes only and not medical advice. Consult a healthcare professional for personal medical guidance.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.